Browsing index pages (3 articles)
↧
BioSante PK study adds to LibiGel safety and efficacy confidence
CEO Stephen M. Simes BioSante Pharmaceuticals’ (NASDAQ:BPAX) successful pharmacokinetic study of its LibiGel (testosterone gel) treatment for female sexual dysfunction, specifically hypoactive sexual...
View ArticleHadasit Bio taps hotbed of innovation at Israel hospital
Hadasit Bio-Holdings (OTCBB: HADSY; TASE: HDST), operating as the technology transfer financing arm of Israel’s Hadassah Medical Center, has built a portfolio of promising, early-stage biotech...
View ArticleCEL-SCI on cusp of cancer game-changer
After a decades-long odyssey, with plenty of bumps along the way, CEL-SCI (AMEX:CVM) of Vienna, Va. has begun the final clinical lap with its Multikine immunotherapy that could turn into a paradigm...
View Article
Browsing index pages (3 articles)